Answers are grounded in this paper and cite their sources.
Urinary tract infections (UTIs) are among the most common healthcare-associated infections worldwide. The study aimed to assess the prevalence of Integron Classes and their correlation with demographic data and multidrug-resistance (MDR) in E.coli isolates obtained from inpatients and outpatients with UTI in Sari, Iran. A total of 100 non-repetitive uropathogenic Escherichia coli (UPEC) isolates were collected from urine specimens of patients between April to December 2024. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disk diffusion method. The presence of integrons ( intI1 , intI2 , and intI3 ) was investigated by PCR. The highest resistance rates were observed against ampicillin (66.6%), followed by ampicillin-sulbactam (62.8%), but the lowest resistance rate was observed for imipenem (1%). In contrast, no resistance was detected against amikacin and tobramycin. Intermediate resistance was identified in only nine antibiotics, Such as nitrofurantoin (19.5%). Overall, 44% of the isolates were MDR, whereas 56% were classified as non-MDR. Notably, among the MDR isolates, a higher proportion was observed in female patients. Of the 100 isolates, 65 (65%) harbored intI1 , and 13 (13%) were harbored intI2 . Notably, no amplification of the intI3 gene was observed in any of the tested isolates. UPEC isolates showed high resistant to commonly used antibiotics and a notable prevalence of class 1 and 2 integrons.Continuous local surveillance of resistance patterns and mobile genetic elements is essential to guide empirical therapy and control the spread of MDR strains. Not applicable.
No takes yet. Share an insight, caveat, or question.
Karimbakhsh et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: